SEC Form 4 · accession 0000899243-15-010212

ZS Pharma, Inc. · ZSPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director

Period of report

Dec 17, 2015

Accepted (ET)

Dec 21, 2015 · 6:38 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001459266

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Dec 17, 2015	D	30,750	$90.00	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Employee Stock Option (NQ) 3/1/13	$2.1284	Dec 17, 2015	D	448,453	D	Mar 1, 2014	Feb 28, 2023	Common Stock	448,453	D
Employee Stock Option (ISO) 1/25/14	$5.616	Dec 17, 2015	D	39,566	D	Jan 25, 2015	Jan 24, 2024	Common Stock	39,566	D
Employee Stock Option (NQ) 1/25/14	$5.616	Dec 17, 2015	D	132,473	D	Jan 25, 2015	Jan 24, 2024	Common Stock	132,473	D
Employee Stock Option (ISO) 7/8/14	$27.16	Dec 17, 2015	D	2,864	D	Jul 7, 2015	Jul 6, 2024	Common Stock	2,864	D
Employee Stock Option (NQ) 7/8/14	$27.16	Dec 17, 2015	D	74,748	D	Jul 7, 2015	Jul 6, 2024	Common Stock	74,748	D
Employee Stock Option (ISO) 6/18/15	$55.57	Dec 17, 2015	D	1,799	D	Jun 18, 2016	Jun 17, 2025	Common Stock	1,799	D
Employee Stock Option (NQ) 6/18/15	$55.57	Dec 17, 2015	D	73,201	D	Jun 18, 2016	Jun 17, 2025	Common Stock	73,201	D

F1Includes 12,500 shares in the form of restricted stock units and 443 shares acquired under the Employee Stock Purchase Plan on December 9, 2015